GB SARS-CoV-2 Influenza A/B Multiplex PCR (Flu A/B, N)
GB SARS-CoV-2 / Influenza A/B Multiplex RT-PCR detects Flu A, Flu B, and SARS-CoV-2 in a single test. Internal extraction control, LoD: SARS-CoV-2 1000, Flu A 500, Flu B 250 copies/mL. Platform-flexible.
PRODUCT DESCRIPTION
The GB SARS-CoV-2 Influenza A/B Multiplex PCR Kit is an in vitro diagnostic real-time RT-PCR assay designed for simultaneous qualitative detection of SARS-CoV-2 (N gene), Influenza A (M1 gene), and Influenza B (NS1 gene) in respiratory tract specimens (nasopharyngeal/oropharyngeal swabs, nasal swabs, mid-turbinate swabs).
<br>
<br>
It includes RNase P as an extraction control to monitor sample quality and detect extraction or amplification failures. The limits of detection are approximately 1000 copies/mL for SARS-CoV-2, 500 copies/mL for Influenza A, and 250 copies/mL for Influenza B. Reagent is CE certified and validated across major platforms including GB AIO System, QuantStudio™ 5, Bio-Rad CFX96, and QIAGEN RGQ Real-Time PCR Systems. Ideal for differentiating multiple respiratory pathogens during flu season and improving diagnostic throughput.
FEATURE
SPECIFICATION
| Number of tests | 100 |
| Targets | SARS-CoV-2 (N gene) / Influenza A (M1) / Influenza B (NS1) |
| Extraction Control | RNase P |
| Extraction Platform (compatible) | Magnetic beads / Column technology |
| Sample type | Respiratory specimens (i.e., nasopharyngeal/oropharyngeal swabs, nasal swabs and mid-turbinate swabs specimens) |
| PCR Instrument (compatible) | GBC AIO System, Qiagen, Roche, Thermo, BioRad |
| Sensitivity (LoD) | influenza A virus: 500 copies/mLinfluenza B virus: 250 copies/mLSARS-CoV-2 virus: 1000 copies/mL |
| Certification | RUO |
ORDERING INFORMATION
| Catalogue No. | Product |
|---|---|
| 4PCO102E | GB SARS-CoV-2 Influenza A/B Multiplex – 100T |